BN Business News
Add your company to Business Communicator →

Business · 10/08/2020Updated: 10/17/2026 · 1 min read

FDA Releases Draft Guidance for Industry on Drug-Drug Interaction Assessment for Therapeutic Proteins

Summary

The Food and Drug Administration (FDA) has released a draft guidance for industry titled "Drug-Drug Interaction Assessment for Therapeutic Proteins," which aims to help pharmaceutical companies assess the potential for drug interactions with therapeutic proteins.

Original source language: Federal Register — Food and Drug AdministrationOpen original release →

Explore insights

Business insights →